Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.610
-0.090 (-5.29%)
Jun 5, 2026, 4:00 PM EDT - Market closed
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $24.89 million as of June 5, 2026. Its market cap has increased by 52.84% in one year.
Market Cap
24.89M
Enterprise Value
26.58M
1-Year Change
52.84%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $24.89M, a decrease of -68.64%. That is a compound annual growth rate of -22.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 24.89M | 45.85% |
| Dec 31, 2025 | 17.07M | 229.00% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
| Dec 21, 2021 | 79.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 28.61M |
| Barinthus Biotherapeutics | 28.19M |
| BriaCell Therapeutics | 28.10M |
| Serina Therapeutics | 27.71M |
| NeuroSense Therapeutics | 27.58M |
| Kyntra Bio | 27.57M |
| Skye Bioscience | 27.22M |
| Dyadic International | 26.36M |